The Bredesen Protocol is named after Dr. Dale Bredesen, a physician, neuroscience researcher, and internationally recognized expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. Currently affiliated with The Buck Institute on Aging and UCLA he is now the Chief Medical Officer of MPI Cognition which has lead the way in the fight to prevent Alzheimer’s disease and reverse early Alzheimer’s disease. In a September 2014 paper published by Dr. Bredesen and his team he demonstrated the first reversal of cognitive decline in patients with early Alzheimer’s disease and its precursors, Mild Cognitive Impairment and Subjective Cognitive Impairment. Further research lead to a follow up publication in 2016 in which Dr. Bredesen demonstrated not just reversal of memory decline, but reversal of the physical and functional changes of Alzheimer’s disease as it affects the brain proving unequivocally that it is possible to alter the course of this devastating illness and impact the lives of the millions of Americans affected by it. In his soon to be published book The End to Alzheimer’s Dr. Bredesen outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that trigger “downsizing” in the brain. The protocol provides specific targets, laboratory tests, nutraceutical strategies, and lifestyle changes needed to achieve the rebalancing that must take place for his protocol to be effective.